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Introduction
Noncommunicable diseases, including cardiovascular disease, 
cancer, respiratory diseases and diabetes, cause an estimated 
41 million deaths each year.1 Fifteen million of these deaths 
occur in people aged 30–69 years,1 at a time of life when 
people are working and more likely to have dependants. Over 
12 million (85%) of these premature deaths occur in low- and 
middle-income countries, where health systems may be fragile 
and access to treatments suboptimal.1 So far, progress towards 
global goals (Box 1) and political commitments on noncom-
municable diseases has been disappointing.4 Unless urgent 
action is taken, the burden of mortality and disability from 
noncommunicable diseases will increase substantially, driven 
by population growth, longer life-expectancies and the global 
diffusion of risk factors such as tobacco use, harmful alcohol 
use, obesity, poor diet and sedentary lifestyles.5
The effective use of law and regulation lies at the heart 
of successful national noncommunicable disease action 
plans.6 Law includes international agreements, national and 
subnational legislation, subsidiary legislation (also known as 
regulations) and other executive instruments, and decisions of 
courts and tribunals. As a broader concept, regulation includes 
legislation, fiscal policies (such as taxes and subsidies) and 
other legally binding standards. Recognizing the power of law 
to improve the public’s health, the World Health Organization 
(WHO) offers technical assistance to governments on appro-
priate legal strategies (Box 2). Constraints and challenges in 
using law effectively at the national level include the lack of 
personnel with legal training or expertise, lack of resources for 
enforcement, and the influence of vested commercial interests 
in drafting, implementing and enforcing laws. Despite these 
challenges, law remains an important tool for taking action 
to reduce the burden of these diseases. Encouragingly, heads 
of state and governments have committed to promoting and 
implementing “policy, legislative, and regulatory measures, 
including fiscal measures”10 to address noncommunicable 
disease risk factors and to developing legal expertise to inte-
grate “public health-related legal issues into noncommunicable 
disease country support.”11
This paper identifies some important areas of intersection 
between law and prevention and control of noncommunicable 
diseases, arguing that law lies at the centre of effective action. 
We suggest actions that WHO and other health development 
partners could take to strengthen national legal capacities and 
accelerate implementation of legal and regulatory strategies.
Law and noncommunicable diseases
Implementing preventive policies
In 2017, the World Health Assembly endorsed an updated 
set of policy options and cost–effective interventions for re-
ducing the burden of noncommunicable diseases, including 
minimizing the major risk factors (consumption of tobacco, 
alcohol, unhealthy foods and drinks high in sugar).12 Many of 
these recommended policies are legal interventions, requiring 
legislation or executive actions for effective implementation 
(Box 3). Sales of tobacco, alcohol, processed foods and sugar-
sweetened drinks have expanded rapidly in low- and middle-
income countries because of trade and investment liberaliza-
tion, leading to greater foreign direct investment, imports and 
advertising.14,15 Implementing WHO’s evidence-based, highly 
cost-effective policy interventions (called best-buys) should be 
a priority for governments, but requires political commitment, 
funding and strong legal capacity.
The force of law is needed to implement effective poli-
cies for prevention and control of noncommunicable disease 
risks because voluntary implementation will rarely be in 
the commercial interests of food, alcohol and tobacco com-
panies. There are similarities in the ways these industries 
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seek to influence not only legislative 
outcomes, but also the perceptions of 
politicians and the public, the framing 
of issues for debate and the generation 
of favourable evidence.16,17 A growing 
literature illustrates the ways in which 
these industries, their allies and proxies, 
lobby governments, donate to political 
campaigns and undermine scientific 
evidence, seeking to shift the public 
focus from healthy public policies to-
wards personal responsibility and fears 
of paternalism.16,17 Industry may also 
seek to pre-empt enforceable standards 
by implementing weaker, self-regulatory 
codes or may lobby to increase industry 
influence through partnerships and 
co-regulatory approaches.18 When 
regulating and dealing with these in-
dustries, governments and international 
institutions should implement rigorous 
conflict-of-interest policies to avoid 
inappropriate forms of influence.16
Apart from seeking to reduce non-
communicable disease risk factors, law 
is an important tool for establishing in-
stitutional and governance mechanisms 
to support public health functions. For 
example, Samoa’s Health Promotion 
Act, enacted in 2013, established the 
Samoa Health Promotion Foundation, 
giving it a legislative mandate to engage 
in health promotion, fund research and 
advise the health minister.19 Through 
executive action, governments can 
also establish a national coordination 
mechanism to implement a whole-
of-government approach to policy 
implementation that ensures policy 
coherence and mutual accountability 
of those ministries that have a bearing 
on noncommunicable disease risks. An 
example is Mexico’s National Council 
for the Prevention and Control of 
Chronic Noncommunicable Diseases, 
which brings together the heads of na-
tional executive agencies to coordinate 
cross-sectoral actions and policies.20 
The WHO Independent High-level 
Commission on noncommunicable 
diseases has emphasized that action 
must start at the top, with the president 
or prime minister of a country leading a 
multisectoral national response.4
Constitutional rights
The constitution of many countries 
guarantees health-related rights to their 
population.21 Constitutional rights not 
only limit parliamentary powers, but 
may permit individuals or groups to 
claim remedies for interference with 
their rights. In such countries, health-
related rights may provide one avenue 
for challenging actions (and omissions) 
by governments and corporations that 
are harmful to health, as seen in India 
and Uganda (Box 4).22–24
On the other hand, national con-
stitutions typically protect a range of 
non-health-related rights that may 
conflict with public health policies. In 
some countries, the right to freedom of 
expression protects commercial speech, 
which may undermine efforts to restrict 
the marketing of tobacco, alcohol, un-
healthy food and drinks, and breastmilk 
substitutes. Civil society organizations 
have also relied successfully on the right 
to freedom of expression to resist efforts 
to supress information about the health 
effects of sugary drinks, as illustrated by 
an example from Colombia (Box 4). 25
International human rights
International law can also influence 
national policies on noncommunicable 
disease prevention and control. For 
example, parties to the WHO Frame-
work Convention on Tobacco Control 
have assumed an obligation under 
international law to implement policies 
on reduction in demand and supply 
of tobacco products.27 Most countries 
have also ratified at least one interna-
tional agreement recognizing the right 
to health or other health-related rights. 
Such agreements include the WHO 
Constitution, various United Nations 
(UN) conventions (e.g. the Interna-
Box 1. Global targets for reductions in noncommunicable disease risk factors
Global Monitoring Framework on noncommunicable diseases (World Health Organization)2
Overall target:
• by 2025, a 25% relative reduction in mortality from cardiovascular disease, cancer, diabetes 
and chronic respiratory diseases in persons aged 30–70 years.
Eight supporting targets:
• 10% relative reduction in harmful use of alcohol;
• 10% relative reduction in prevalence of physical inactivity;
• 30% relative reduction in mean average population salt intake;
• 30% relative reduction in prevalence of tobacco use (persons older than 15 years);
• 25% relative reduction in raised blood pressure;
• 0% increase in diabetes and obesity;
• 50% coverage for drug therapy and counselling for those at risk for cardiovascular disease;
• 80% coverage of affordable technologies and essential medicines for treating 
noncommunicable diseases in both public and private facilities.
Sustainable development goal 3 (United Nations)3
Target 3.4: 
• by 2030, reduce by one third premature mortality from noncommunicable diseases through 
prevention and treatment and promote mental health and wellbeing.
Box 2. Scope of technical work on law and noncommunicable diseases by the World 
Health Organization
The World Health Organization’s (WHO) work at the intersection of law and noncommunicable 
diseases includes:
• supporting governments to develop laws and regulations on health matters through 
technical assistance, training and provision of technical resources;
• comparative analysis of laws in different jurisdictions for WHO publications, including 
biannual reports on the global tobacco burden;
• analysing litigation and industry opposition to policies and laws, and integrating lessons 
learnt into technical assistance and resources;
• gathering evidence in support of effective public health laws and policies in Member States;
• providing assistance to Member States in litigation matters;
• intervening in legal disputes; for example, through the amicus briefs filed in disputes over 
tobacco control laws7–9; and
• engaging with other inter-governmental organizations on legal and normative issues.
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tional Covenant on Economic, Social 
and Cultural Rights; the Convention 
on the Rights of the Child; the Conven-
tion on the Elimination of All Forms of 
Discrimination Against Women) and 
regional agreements (e.g. the African 
Charter on Human and People’s Rights).
Unlike the WHO Framework Con-
vention on Tobacco Control, health-
related provisions in human rights 
treaties are often expressed in general 
terms and were not framed with non-
communicable disease risk factors in 
mind.28 Nevertheless, the Committee on 
Economic, Social and Cultural Rights, 
the treaty-monitoring body for the 
International Covenant on Economic, 
Social and Cultural Rights, has identi-
fied core obligations arising under the 
right to health that are directly relevant 
to noncommunicable diseases. These 
include the obligation to ensure access 
to health services without discrimi-
nation; nutritionally adequate food; 
safe and potable water; and essential 
medicines.29 Under the Covenant, UN 
Member States also have an obligation 
to respect, protect and fulfil the right to 
health. The obligation to protect requires 
countries to prevent third parties, in-
cluding corporations, from violating this 
right. Member States must also remedy 
regulatory failures, such as “failure to 
discourage production, marketing and 
consumption of tobacco, narcotics and 
other harmful substances.”29 The obliga-
tion to fulfil the right to health addresses 
the problem of inaction by Member 
States, requiring them to adopt “legisla-
tive, administrative, budgetary, judicial, 
promotional and other measures” to-
wards full realization of the right.29
Each country’s compliance with its 
human rights obligations is reviewed 
through a process known as Universal 
Periodic Review, overseen by the UN 
Human Rights Council. Universal Pe-
riodic Review provides an impetus for 
governments to strengthen health-relat-
ed rights,30 and may assist governments 
defending rights-based claims made by 
corporations, such as freedom of ex-
pression or property rights. During this 
process, human rights treaty bodies may 
draw attention to priority risk factors, 
urging Member States to implement 
effective policies on noncommunicable 
diseases. For example, concerned about 
increasing food insecurity (including 
its link with obesity) and low levels of 
breastfeeding, the Committee urged the 
United Kingdom of Great Britain and 
Northern Ireland to implement national 
policies on breastfeeding in accordance 
with World Health Assembly resolutions 
and the International Code of Market-
ing of Breast-milk Substitutes; increase 
taxes on unhealthy foods and sugar-
sweetened drinks; and “consider adopt-
ing strict regulations on the marketing of 
such products, while ensuring improved 
access to healthy diets.”31 Similarly, in 
2014, the Committee expressed concern 
about tobacco addiction in Indonesia, 
recommending indoor smoking bans 
in public buildings and workplaces, 
and a ban on tobacco advertising and 
sponsorship.32 In 2007, the Committee 
on the Rights of the Child recommended 
that Chile “take necessary measures to 
reduce and prevent the incidence of 
obesity among children.”33 This report 
could strengthen Chile’s position in 
counteracting litigation initiated by food 
producers against the country’s restric-
tions on marketing to children.
International human rights law 
and practice is a neglected resource 
for governments seeking to reduce the 
burden of noncommunicable diseases. 
Analysis of specific health rights within 
international human rights agreements 
provides important guidance in many 
areas, such as tobacco control and 
marketing of foods and beverages.34 
International treaty bodies could make 
greater use of the WHO Framework 
Convention on Tobacco Control27 and 
authoritative sources of guidance on 
risk factors, including the Global Ac-
Box 3. Legally oriented best-buys and policy interventions for noncommunicable 
disease prevention and control
Highly cost–effective policy interventions (best-buys) recommended by the World Health 
Organization include:
• increasing excise taxes and prices of tobacco products and alcoholic beverages;
• eliminating peoples’ exposure to second-hand tobacco smoke in all indoor workplaces, 
public places and public transport;
• comprehensive bans on tobacco advertising, promotion and sponsorship;
• implementing plain tobacco packaging and/or graphic health warnings on all tobacco 
packages;
• comprehensive bans or restrictions on alcohol advertising across multiple forms of media;
• enforcing restrictions on the physical availability of alcohol via reduced hours of sale in 
retail outlets;
• mandatory product reformulation and front-of-pack labelling to help people to reduce 
salt intake.
Other cost–effective policy interventions include:
• implementing and enforcing drink-driving laws and blood alcohol concentration limits via 
sobriety checkpoints;
• eliminating industrial trans-fats through legislation banning their use in food manufacturing;
• taxation of sugar-sweetened beverages at a rate high enough to encourage people to 
reduce sugar consumption.
Other recommended, legally-oriented policy options include:
• measures to minimize illicit trade in tobacco products;
• bans on cross-border tobacco advertising;
• setting minimum alcohol prices;
• enforcing a minimum age for purchase of alcoholic beverages;
• reducing the density of retail alcohol outlets;
• restricting or banning promotions of alcoholic beverages targeting young people;
• requiring labels for alcoholic beverages to include information about the harm caused by 
alcohol;
• implementing subsidies to increase people’s intake of fruits and vegetables;
• replacing trans-fats and saturated fats with unsaturated fats through mandatory 
reformulation, product labelling, fiscal or agricultural policies;
• implementing nutrition labelling to encourage people to reduce consumption of energy, 
sugars, sodium and fats;
• improving urban environments to ensure ease of walking, connectivity and access to public 
transport to encourage people to engage in more physical activity.
Source: World Health Organization.13
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tion Plan on Prevention and Control 
of noncommunicable diseases,2 when 
evaluating Member States’ compliance 
with their obligations under human 
rights treaties.
Trade and investment 
agreements
International trade law is another im-
portant area of law that impacts on risk 
factors for noncommunicable diseases. 
International trade and investment 
agreements can affect noncommuni-
cable disease risk factors in complex 
ways; for example, by reducing prices, 
increasing competition, and facilitating 
international trade and investment in 
harmful products, such as tobacco and 
alcohol.35
In legal terms, trade and invest-
ment agreements discipline how states 
can regulate. For example, World Trade 
Organization (WTO) law establishes 
core principles of trade law, including 
prohibiting discriminatory regulation, 
requiring that regulation be not more 
trade restrictive than necessary to pro-
tect health, and requiring minimum 
standards of protection for intellectual 
property rights. The WTO panels have 
applied these principles in adjudicat-
ing legal disputes concerning tobacco 
control. For example, a WTO panel held 
that United States legislation banning 
flavoured tobacco, but exempting men-
thol-flavoured products discriminated 
in favour of domestic products.36 More 
recently, a WTO panel upheld Australia’s 
tobacco plain packaging laws as not 
more trade restrictive than necessary 
and not an unjustifiable encumbrance 
on the use of trademarks.7 WTO com-
mittees have also discussed legal mea-
sures to reduce harmful alcohol use37 
and improve healthy diets,38 although 
such measures have not resulted in 
WTO disputes.
Regional trade agreements are in-
creasingly important. Customs unions, 
such as the European Union, can lead 
to harmonization of laws, such as 
through the 2014 European Tobacco 
Products Directive.39 However, rules 
concerning free movement of goods, 
state aid and communications can also 
be used to challenge fiscal and regula-
tory measures. Examples include the 
(recent unsuccessful) challenge to the 
introduction of minimum unit pricing 
on alcoholic beverages in Scotland,40 
limitations on Sweden’s ability to restrict 
alcohol marketing originating in the 
United Kingdom,41 and the scrapping 
of a Finnish confectionary tax because 
of rules concerning state aid.42
Investment treaties, whether bilat-
eral or as investment chapters in trade 
agreements, can also impact on legisla-
tion concerning noncommunicable 
diseases. The tobacco company Philip 
Morris International recently challenged 
tobacco control laws in Australia and 
Uruguay. These claims, which were 
unsuccessful but expensive to defend, 
concerned plain tobacco packaging, 
health warnings and other labelling 
requirements implemented in response 
to the WHO Framework Convention on 
Tobacco Control.8,9
Litigation and complaints 
mechanisms
Challenges to policies for prevention 
and control of noncommunicable dis-
eases are frequently resolved in national 
courts and tribunals, as illustrated again 
by the alcohol industry’s 5-year at-
tempt to overturn Scotland’s legislation 
on minimum alcohol pricing.43 The 
tobacco, food and alcohol industries 
are increasingly suing governments, 
relying on constitutional and human 
rights guarantees, although with mixed 
success.44
On the other hand, litigation and 
use of other complaints mechanisms 
can be used to hold industry to account 
for harm caused by their products, to 
improve access to medicines and to 
vindicate other health-related rights.6 
Tobacco litigation in the United States 
has had a major impact. A Department 
of Justice lawsuit found that for half a 
century the tobacco industry engaged 
in a pattern of fraudulent conduct to 
deceive the American public about 
the effects of cigarettes on health.45 
Complaints made under consumer 
protection laws are another underused 
tool. For example, an Australian court 
imposed a fine of more than 2 million 
Australian dollars against the Heinz 
food company for engaging in false and 
misleading conduct by advertising that 
a chewy fruit snack, containing about 
Box 4. Examples of constitutional rights litigation affecting noncommunicable disease 
risk factors
Constitutional rights may provide remedies for groups harmed by government or corporate 
actions or omissions:
India
In India, individuals may petition the Supreme Court to enforce fundamental rights and liberties 
in the Indian Constitution. The Supreme Court has ruled that the exposure of non-smokers to 
tobacco smoke violates the constitutional right to life and personal liberty.22 The Court issued 
an order, subsequently implemented through national legislation, required federal and state 
governments to implement smoking bans in several public settings. The Supreme Court has also 
held that the right to life in the Constitution encompasses a right to live with human dignity, 
which encompasses the right to food. In a series of orders, the Court has expanded coverage 
and legal entitlements under food assistance programmes.23
Uganda
The High Court of Uganda has ruled that the emission of tobacco smoke, dust and smell from 
a tobacco factory in a residential area violates the right to a healthy and clean environment, as 
protected in the Ugandan Constitution.24 Finding that the National Environment Management 
Authority had failed in its responsibilities, the court ordered the relocation of the factory.
Colombia
A Colombian civil society organization, Educar Consumidores, successfully challenged an order 
given by a regulatory authority, the Superintendency of Industry and Commerce, directing 
Educar Consumidores to cease transmission of a television and radio campaign that pointed 
to the quantities of sugar in sugary drinks and their harmful effects. Educar Consumidores and 
representatives of another civil society organisation successfully petitioned for review by the 
Colombian Constitutional Court, which held that the ban violated consumers’ constitutional 
right to receive information – and to inform others – about the health risks of sugary drinks.25
On the other hand, constitutional rights may conflict with public health policies on 
noncommunicable diseases:
United States of America
The city of San Francisco passed a local ordinance requiring billboards advertising soda drinks 
to display a warning that added sugars contribute to obesity, diabetes and tooth decay. In 
response, the American Beverage Association obtained an injunction on the basis that a 
mandatory warning infringed their First Amendment rights to free speech.26 An appeals court 
has agreed to re-hear this case.
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two-thirds sugar, was beneficial to the 
health of children aged 1–3 years.46
Effective use of law
Legislation and executive actions are 
essential for noncommunicable disease 
prevention and control, while many of 
the challenges to effective national plans, 
such as defending litigation initiated 
by industry, also call for technical legal 
expertise. However, governments face 
major obstacles to using law effectively, 
including lack of trained personnel, 
lobbying by powerful industry groups 
and uncertainty about the extent of their 
country’s obligations under trade and 
investment agreements.16 Nevertheless, 
as Box 5 illustrates, governments can 
overcome these challenges and pass 
innovative laws for prevention and 
control of noncommunicable disease 
risk factors.
Public health advocates have called 
on the World Health Assembly to make 
bold use of its legal powers, through a 
convention on alcoholic beverages56 or 
obesity57 and unhealthy diets. A global 
coordinating agency for noncommuni-
cable diseases has also been proposed, to 
encourage public and private financing, 
aligned with the sustainable develop-
ment goals.58 However, even in the 
absence of these major reforms, we see 
opportunities for governments and their 
development partners, including WHO, 
to strengthen national noncommuni-
cable disease prevention and control.
Sharing good practices
The WHO Independent High-level 
Commission on noncommunicable 
diseases encouraged governments to 
use their “full legal and fiscal powers 
to achieve public health goals.”4 This 
includes regulating harmful products 
and practices, and strengthening the 
institutions, functions and official roles 
that are needed to ensure compliance 
with legal standards.6 Effective use of 
law requires budgetary resources for en-
forcement, including training. Distinct 
from its law-making role, WHO’s power 
to develop soft (non-binding) normative 
standards, together with its capacity to 
convene and disseminate expert knowl-
edge, remain powerful tools. WHO is 
already developing technical resources 
to support regulatory actions by govern-
ments; for example, implementing plain 
packaging of tobacco products59 and 
the International Code of Marketing of 
Breast-milk Substitutes.60 WHO, with 
its development partners, should invest 
further to increase technical resources 
in law and regulation.
WHO could also facilitate the dif-
fusion of policy across Member States 
by creating opportunities for govern-
ments that are leading the way to share 
their practical experiences of drafting, 
implementing and enforcing laws and 
fiscal policies.10 Since legal systems vary 
widely, such exchanges among officials 
and stakeholders in different countries 
are likely to be more productive than 
exhaustively cataloguing health laws or 
promoting model legislation. Recent 
experience with plain packaging of 
tobacco products shows that technical 
activities such as training workshops, 
online platforms linking people who 
work in a common field and compara-
tive analysis of laws and litigation can 
also facilitate policy diffusion.
Mobilizing the legal workforce
Building legal capacity means mobi-
lizing a workforce with the technical 
skills to navigate legal issues arising in 
key areas of noncommunicable disease 
prevention and control.61 Such efforts 
could help to translate evidence and 
WHO guidance into country-level ac-
tion. Creating a platform for lawyers, 
legislators, educators and public health 
experts to interact may not only improve 
the exchange of advice and information 
across governments, civil-society orga-
nizations and academia, but also provide 
mentors for young leaders working on 
reform of laws on noncommunicable 
diseases in low-resource countries.
Leadership requires greater invest-
ment in legal capacity within WHO 
and other agencies working in health 
development, and careful assembling of 
a legal workforce. Donor funding for a 
dedicated public health law programme 
within WHO to support countries in 
implementing best-buy policy interven-
tions could have a substantial impact.62 
Within available resources, we see two 
key areas where global leadership could 
strengthen legal capacities.
First, WHO could facilitate profes-
sional exchanges and mutual support 
among those who use legal knowledge 
in key practice areas. Fostering such a 
transnational network could be achieved 
Box 5. Examples of innovation in legal and regulatory approaches to prevention and 
control of noncommunicable diseases
Chile
In 2015, the Chilean Ministry of Health published regulations on the nutritional composition 
of food products, implementing an earlier law passed in 2012.47,48 These laws require packaged 
food that exceeds limits set (per 100 g or per 100 mL) for energy, sodium, sugar or saturated 
fat, respectively, to be prominently labelled as “high in” each of these nutrients. The same law 
prohibits food advertising that is directed at children younger than 14 years where the food 
exceeds the limits for energy, sodium, sugar or saturated fat. Finally, foods that exceed the cut-off 
points for over-consumed nutrients cannot be sold in pre-school, primary or secondary school.
Mexico
Mexico’s 1 peso per litre tax on sugar-sweetened drinks, implemented in 2014, resulted in a 
seasonally adjusted reduction in consumption of taxed beverages of 5.5% in 2014, and 9.7% in 
2015, compared with estimates based on trends in consumption before the implementation 
of the tax.49
South Africa
In 2013, South Africa introduced regulations under its Foodstuffs, Cosmetics and Disinfectants 
Act to impose maximum limits for sodium across 13 categories of food including bread, breakfast 
cereal and porridge, processed meat, savoury snacks and potato chips.50 These limits took effect 
in June 2016, with lower limits to be phased in from 30 June 2019. One study estimated these 
regulations could avoid 5600 cardiovascular disease deaths per year.51
United Kingdom of Great Britain and Northern Ireland
Effective from April 2018, the soft drinks levy introduced in the United Kingdom has two tax 
levels that apply according to the sugar content: 18 pence for drinks with > 5 g sugar per 100 
mL, and 24 pence for drinks with > 8 g sugar per 100 mL.52 The levy incentivized reformulation 
of products by soft-drink manufacturers even before the tax took effect, reducing expected 
revenues from pounds sterling (£) 520 to £240 million in the first year of the law.
United States of America
Six States (California, Hawaii, Maine, Massachusetts, New Jersey, Oregon) and more than 350 cities 
and counties, including New York city, have raised the minimum purchasing age for tobacco 
from 18 to 21 years.53 In California and New York city, a minimum age of 21 years is required to 
purchase both cigarettes and electronic cigarettes.54,55
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online, with support for legal practi-
tioners working in key thematic areas, 
countries and regions, and in different 
languages. With appropriate support, 
these communities of practice will 
grow and evolve, seeking out strategic 
opportunities, developing novel legal 
arguments, providing expert evidence 
in litigation (through filing of amicus 
briefs), documenting case studies and 
developing technical resources in areas 
of need.
Second, knowledge provides the 
foundation for action. In the context 
of tobacco control, for example, data-
bases of case law and legislation facilitate 
comparative analysis and assist lawyers 
and health professionals to anticipate 
tobacco industry strategies.63 No com-
parable resource exists for taking action 
on unhealthy diets or harmful use of 
alcohol. Consequently, industry legal 
arguments are neither systematically 
tracked nor easily anticipated.
Building on local innovations
Although prevention and control of 
noncommunicable diseases ideally 
require a national response, state, city 
and local governments can be powerful 
innovators (Table 1). Unlike national 
governments, smaller, defined localities 
often have more homogeneous constitu-
encies, smaller and more efficient ad-
ministrations and less time-consuming 
legislative processes. In response to 
political activism, social mobilization 
and specific social, economic and demo-
graphic factors, local and city adminis-
trations can become laboratories for in-
novation, trialling new legal approaches. 
The impact of these local innovations 
can be evaluated, disseminated and 
implemented both horizontally (to other 
localities) and vertically (at state and 
national levels).64
Local governments have been lead-
ers in many areas of noncommunicable 
disease policy. In the United States, 
local jurisdictions were the first to 
impose higher taxes, marketing restric-
tions and bans on smoking in public 
places, among other interventions.65 
Some cities and towns have adopted 
a range of additional strategies, such 
as banning trans-fatty acids from the 
food supply, raising the minimum 
purchasing age for tobacco products 
and imposing health-based taxes on 
sugar-sweetened drinks.66
Coordinating regional action
Regionally coordinated action can ac-
celerate the implementation of legisla-
tion, particularly by smaller countries. 
The best opportunities exist in regions 
that have a strong history of coopera-
tive action. WHO’s regional offices and 
other regional political groupings (e.g. 
the Pacific Community, the Caribbean 
Community, the African Union, the 
Association of Southeast Asian Nations 
or the Organization of American States) 
could lead, coordinate and support na-
tional noncommunicable disease poli-
cies. Deliberate, planned, regional action 
could benefit small, remote and vulner-
able populations whose governments 
may otherwise engage in prevention and 
control in a piecemeal fashion and at a 
slower rate. Regional action allows more 
efficient use of legal resources, although 
careful groundwork is needed to create a 
shared vision and agreed principles for 
action. Box 6 summarizes an example 
from WHO’s Regional Office for the 
Eastern Mediterranean.
Table 1. Examples of local innovations in prevention and control of noncommunicable diseases in the United States of America
Policy innovation and example Description Reference
Information disclosure
Calorie labelling rules Restaurant chains and food retailers in New York city must disclose 
calorie counts on menu boards for standard menu items
New York City Health 
Code §81.50 (2017)
Soda warning rule Billboards advertising sugar-sweetened drinks in San Francisco city must 
contain a health warning about the impact of added sugars on obesity, 
diabetes and tooth decay
San Francisco Health 
Code art. 42 §4203(a) 
(2015)
Haemoglobin A1C registry New York city’s health code makes glycated haemoglobin (a measure of 
blood sugar control) a reportable condition by pathology laboratories. 
The registry helps to identify patients with poorly controlled diabetes or 
who need follow-up care
New York City Health 
Code §13.07 (2006)
Marketing restrictions
School advertising law Maine was the first state to prohibit brand-specific advertising of food or 
beverages in school buildings or on school grounds
Title 20-A Maine Rev. Stat. 
Ann §6662 (2007)
Healthy food incentives ordinance Fast-food restaurants in San Francisco city are prohibited from providing 
free toys in children’s meals
San Francisco Health 
Code art. 8 §§471.1 to 
471.9 (2011)
Taxation
Sugar-sweetened beverage tax The city of Berkeley was the first jurisdiction in the country to impose an 
excise tax of 1 cent per ounce on sugar-sweetened drinks 
Berkeley Municipal Code 
Chapter 7.72 (2014)
Sugar-sweetened beverage tax Philadelphia was the first major city to levy a tax of 1.5 cents per 
ounce on sugar-sweetened drinks and to earmark tax revenue for 
improvements to parks, libraries and recreation centres
Philadelphia Code §§19–
4101 to 4108 (2016)
Built environment: zoning
Urban agriculture incentives California State’s Urban Agriculture Incentive Zones Act reduces property 
taxes for landowners who enter a contract to permit small-scale 
agriculture or animal husbandry for at least 5 years on vacant lands
Cal Govt Code §51042 
(2017
Ordinance to control prevalence of fast-
food outlets 
The city of Los Angeles limits new fast-food restaurants in areas with an 
over-concentration of fast-food outlets
L.A. Cal. Ordinance 
180103 (2008)
§: section; §§: sections.
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Conclusion
Legislative and regulatory actions lie 
at the heart of successful national and 
local strategies for noncommunicable 
disease prevention and control. How-
ever, the role of law as a public policy 
tool, translating scientific evidence 
and normative guidance into action, 
receives inadequate attention amid 
the dominance of other disciplines in 
global health development. This needs to 
change. Rapid progress in tobacco con-
trol has not been accidental, but reflects 
agreement about the critical importance 
of law to tobacco control – leading, 
in turn to adoption of strong, legally-
binding standards at international and 
national levels. The rapid progress also 
reflects global investment in capacity-
building, technical assistance to WHO 
Member States, and expansion of legal 
resources, assisted by organizations such 
as Bloomberg Philanthropies and the 
Bill & Melinda Gates Foundation. These 
factors, which have accelerated progress 
in tobacco control, are not yet present 
for other noncommunicable disease 
risk factors such as unhealthy diets and 
harmful use of alcohol. Legal and regu-
latory action must move to the centre 
of national noncommunicable disease 
action plans. This requires high-level 
leadership at global and national levels, 
developing evidence-based legislation 
through transparent processes, enforc-
ing it, evaluating its effectiveness and 
building legal capacities. ■
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摘要
预防和控制非传染性疾病所需的法律能力
法律是成功制订预防和控制非传染性疾病的国家战略
核心。我们所说的法律是指国际协议、国家和地方法
律、法规和其它执行文书 , 以及法院和法庭的判决。
但是 , 人们对法治在全球卫生发展中的重要作用知之
甚少 , 且法学的作用往往被医学、公共卫生和经济学
等其它学科所替代。本文确定了法律与非传染性疾病
交叉的关键领域 , 以法治工具作为实施预防和控制主
要风险因素政策的开端。我们明确世界卫生组织及其
合作伙伴可以采取行动来动员合法劳动力 , 加强法律
能力并支持法律在国家层面上的有效利用。法律和法
规行为必须转向国家非传染性疾病行动计划的中心。
这需要在国际和国家层面上实施基于实证的立法和建
设法律能力的高层领导。
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 6. Example of effective and regionally relevant legal interventions for control of 
noncommunicable diseases by WHO
The World Health Organization Regional Office for the Eastern Mediterranean (WHO-EMRO), 
partnered with the O’Neill Institute for National and Global Health Law at Georgetown 
University, Washington, United Sates of America, to spur legal reform for noncommunicable 
disease prevention and control. The project identified affordable, feasible and cost–effective 
legislative and regulatory interventions that were suitable for implementation in the Eastern 
Mediterranean Region.
The comprehensive dashboard of legal interventions proposed that WHO-EMRO Member 
States prioritize interventions in three key domains: (i) noncommunicable disease governance 
mechanisms requiring multisectoral collaboration, accountability and transparency; (ii) tobacco 
control laws in compliance with the WHO Framework Convention on Tobacco Control;27 and 
(iii) laws to promote healthier diets, such as reducing consumption of sodium and sugar.67
WHO-EMRO committed to support Member States to enact and enforce population health 
improvements through these priority interventions. The project includes implementation 
guidance tools as well as capacity-building initiatives led by multidisciplinary teams of legislators 
and public health experts.68 The EMRO–O’Neill Institute partners published a detailed description 
of the evidence-based legal policies to reduce noncommunicable disease prevalence in the 
Region.69
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Résumé
Capacités juridiques requises pour prévenir et maîtriser les maladies non transmissibles
Le droit est au cœur des stratégies nationales efficaces de lutte 
contre les maladies non transmissibles. Par droit, nous entendons les 
accords internationaux, les législations nationales et infranationales, 
les réglementations et autres instruments exécutifs, et les décisions 
des cours et des tribunaux. Cependant, le rôle vital du droit dans le 
développement de la santé à l'échelle mondiale est souvent mal 
compris, et éclipsé par d'autres disciplines telles que la médecine, la santé 
publique et l'économie. Cet article définit des domaines d'intersection 
clés entre le droit et les maladies non transmissibles, en commençant 
par le rôle du droit en tant qu'outil pour mettre en œuvre des politiques 
visant à prévenir et maîtriser les principaux facteurs de risque. Nous 
mettons en évidence des mesures que l'Organisation mondiale de 
la Santé et ses partenaires pourraient prendre pour mobiliser les 
professionnels du droit, renforcer les capacités juridiques et soutenir 
une utilisation efficace du droit au niveau national. Des mesures 
juridiques et réglementaires doivent être placées au centre des plans 
d'action nationaux pour la lutte contre les maladies non transmissibles. 
Cela nécessite un leadership de haut niveau de la part des dirigeants 
internationaux et nationaux, à travers l'adoption de lois fondées sur 
des données scientifiques et un renforcement des capacités juridiques.
Резюме
Правовой потенциал, необходимый для профилактики и борьбы с неинфекционными заболеваниями
Закон лежит в основе успешных национальных стратегий по 
профилактике и борьбе с неинфекционными заболеваниями. 
Под законом подразумеваются международные соглашения, 
национальное и субнациональное законодательство, 
нормативные акты и другие постановления исполнительных 
органов, а также решения судов и трибуналов. Однако 
исключительно важная роль закона в области развития 
глобального здравоохранения часто плохо осознается 
и перекрывается такими дисциплинами, как медицина, 
общественное здравоохранение и экономика. Настоящий 
документ определяет основные области пересечения между 
законом и лечением неинфекционных заболеваний, начиная 
с роли закона как инструмента для реализации стратегий 
по профилактике и борьбе с ведущими факторами риска. 
Авторы определяют меры, которые могут быть предприняты 
Всемирной организацией здравоохранения и ее партнерами 
по мобилизации юридического персонала, укреплению 
правоспособности и поддержке эффективного использования 
закона на национальном уровне. Правовые и нормативные 
меры должны стать основой для разработки национальных 
планов действий по борьбе с неинфекционными заболеваниями. 
Для этого необходимо заручиться поддержкой мировых 
и национальных лидеров, обеспечить принятие научно 
обоснованных законов и развитие правового потенциала.
Resumen
Fortalecer la capacidad jurídica para la prevención y el control de las enfermedades no contagiosas
La ley es la clave del éxito de las estrategias nacionales para la prevención 
y el control de las enfermedades no contagiosas. Por ley entendemos 
los acuerdos internacionales, la legislación nacional y subnacional, los 
reglamentos y otros instrumentos ejecutivos, así como las decisiones 
de los tribunales y las cortes de justicia. Sin embargo, el papel vital de 
la ley en el desarrollo de la salud mundial a menudo no se comprende 
bien y se ve eclipsado por otras disciplinas como la medicina, la salud 
pública y la economía. Este documento identifica las áreas clave de 
intersección entre la ley y las enfermedades no contagiosas, empezando 
por el papel de la ley como herramienta para implementar políticas de 
prevención y control de los principales factores de riesgo. Se determinan 
las medidas que la Organización Mundial de la Salud y sus asociados 
podrían adoptar para movilizar al personal legal, fortalecer la capacidad 
jurídica y apoyar el uso eficaz de la legislación a nivel nacional. Las 
acciones legales y reglamentarias deben pasar a ser el centro de los 
planes de acción nacionales para las enfermedades no contagiosas. Esto 
requiere un liderazgo de alto nivel por parte de los líderes mundiales y 
nacionales, para promulgar una legislación basada en pruebas y crear 
capacidades jurídicas.
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